Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas
Condition: T Lymphoblastic Leukemia/Lymphoma Intervention: Drug: Chidamide Sponsor: Zhejiang University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Leukemia | Lymphoma | Research | T-cell Lymphoma